RL: Before The Quarter

Here we are again, waiting for another quarter from RL. And of course, the ONLY question I’m being asked is “How much will RL beat by given management’s sandbagging track record, and is it in the stock?”


The answer is they’re going to beat meaningfully. We’ve got ‘em at $1.52 vs. the Street at $1.29 (20%). Then we’ve got 4Q (Mar) at $1.28 vs. the Street at $0.88 (45%).


There are several factors to consider about this quarter.

  1. The company guided to high-teens growth in total company sales, and noted that Retail will lead that growth. Huh?
    1. They guided to high teens for Wholesale too. Fall rollout of Lauren handbags to 150 US doors is partially driving this.
    2. But we’re just at the point now where RL’s retail segment is larger in size than wholesale.
    3. Let me get this straight…two divisions of equal size accounting for 95% of revenue. One will grow high teens, and the other will be more than that. How does that equate to high teens for the parent?
    4. We think that Retail will grow by 30% in the quarter. Why?
      1. First and foremost, The Chinese and Korean licenses are both being folded into Retail – instead of wholesale like all previous licenses have been. Is this just accounting? An optical illusion to goose the perception of growth? Perhaps. But strip out 4% of a 23% top line growth expectation, and I’ll still be impressed.
      2. RL turned on its UK dot.com business in October. This alone should boost e-commerce as a percent of total from 3.5% to 5%. And yes, it carries an incremental margin north of 50%, and serves as the best avenue to flush out goods at end of season.


In aggregate, we have sales  growing by 23%. If we’re right on that, then in order to justify their ‘GM down 100bp’ guidance, we’d need to peg SG&A up near 30% in order to get closer to the consensus. That’s not going to happen.


Is it in the stock? RL saw record selling activity in December by several senior executives. Regardless of what the stats say, my sense from talking to investors is that there simply is no consensus on this name.  But one trend is clear in looking at other names in retail – investors are paying for top-line growth. RL fits right in.


I wouldn’t chase it here, as there’s admittedly not enough controversy in the name. But If we’re right with $6.13, $7.34, and $8.34 for the next three years, respectively, then it suggest 20% CAGR EPS growth with a bullet proof balance sheet. We never like pulling multiples out of the air – but the reality is that others will. Let’s use a number a bit below the growth rate. 18%, or 18x? It suggests $110 today (where the stock is), $130 in a year, and $150 in 2.



Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more

A 'Toxic Cocktail' Brewing for A Best Idea Short

The first quarter earnings pre-announcement today is not the end of the story for Mednax (MD). Rising labor costs and slowing volume is a toxic cocktail...

read more

Energy Stocks: Time to Buy? Here's What You Need to Know

If you're heavily-invested in Energy stocks it's been a heck of a year. Energy is the worst-performing sector in the S&P 500 year-to-date and value investors are now hunting for bargains in the oil patch. Before you buy, here's what you need to know.

read more

McCullough: ‘My 1-Minute Summary of My Institutional Meetings in NYC Yesterday’

What are even some of the smartest investors in the world missing right now?

read more

Cartoon of the Day: Political Portfolio Positioning

Leave your politics out of your portfolio.

read more

Jim Rickards Answers the Hedgeye 21

Bestselling author Jim Rickards says if he could be any animal he’d be a T-Rex. He also loves bonds and hates equities. Check out all of his answers to the Hedgeye 21.

read more

Amazon's New 'Big Idea': Ignore It At Your Own Peril

"We all see another ‘big idea’ out of Amazon (or the press making one up) just about every day," writes Retail Sector Head Brian McGough. "But whatever you do, DON’T ignore this one!"

read more